Doctor Who Fought 8 Years for Children’s Lives Now Hit with Legal Notice
Hyderabad paediatrician Dr. Sivaranjani Santosh, who advocated for clearer ORS labelling, receives legal notice from companies linked to Kenvue and Johnson & Johnson.
A Bombay High Court hearing has exposed a major regulatory gap in India’s diagnostic laboratory system. The Maharashtra government admitted it lacks authority to act against illegal pathology labs, raising concerns about technician run laboratories, patient safety, diagnostic reliability, and the urgent need for a national regulatory framework.
Table of contents [Show]
A recent development in the Bombay High Court has raised a deeply troubling question for the medical fraternity: who regulates the laboratories that generate the diagnostic data on which clinical medicine depends?
During a hearing at the Nagpur Bench, the Maharashtra government informed the court that it currently lacks the legal authority to take action against illegally operated pathology laboratories. The matter arose from a public interest litigation filed by activist Digambar Pajgade, alleging that many diagnostic laboratories are being operated by technicians without supervision by qualified medical professionals.
For clinicians, this revelation should be alarming.
But I ask...If the government allows any Para clinical medical professional to practice allopathy, if BHMS DOCTORS MAY PERFORM SURGERIES BY DOING CRASH COURSE.... CAN'T A LABORATORY COURSE CERTIFICATE HOLDER OWN AND RUN LABORATORIES???
Modern medicine is heavily dependent on laboratory diagnostics. It is often said that nearly 70% of medical decisions rely on laboratory investigations. From diagnosing infections and metabolic disorders to monitoring chemotherapy, anticoagulation, and endocrine diseases, pathology laboratories serve as the backbone of evidence based clinical practice.
Yet the regulatory environment governing these laboratories appears to be far from robust.
The issue highlighted in court reflects a systemic problem: India lacks a comprehensive and uniformly implemented regulatory framework for diagnostic laboratories. While accreditation bodies such as the National Accreditation Board for Testing and Calibration Laboratories promote quality standards, their certification remains voluntary. As a result, many laboratories operate without standardized oversight.
As per the petitioner, Compounding the problem is the growing proliferation of technician run laboratories. Technicians trained through courses such as Diploma in Medical Laboratory Technology (DMLT) play an important role in performing laboratory procedures. However, technical expertise in conducting tests does not equate to medical expertise in interpreting results.
Interpretation of laboratory data requires clinical correlation, knowledge of pathophysiology, and an understanding of disease patterns—skills that are typically acquired through postgraduate medical training in pathology, microbiology, or biochemistry.
Without such oversight, diagnostic reports may become unreliable.
The consequences extend beyond individual patient care. Inaccurate laboratory reports can lead to misdiagnosis, unnecessary treatments, delayed therapies, and avoidable healthcare costs. Moreover, erroneous reporting of infectious diseases can undermine public health surveillance systems.
There is also an important medico legal dimension. Treating physicians often rely on laboratory reports as objective evidence guiding clinical decisions. If those reports originate from poorly regulated facilities, clinicians may face legal vulnerability when complications arise.
The solution is not to diminish the role of laboratory technicians, whose contributions to healthcare are essential. Rather, the focus should be on establishing a structured system of supervision and accountability.
India urgently requires a comprehensive regulatory framework governing diagnostic laboratories. Such a framework should mandate laboratory registration, define qualification requirements for laboratory directors, enforce quality assurance mechanisms, and regulate collection centres that function as extensions of diagnostic facilities.
Additionally, regulatory authorities must be empowered to inspect, penalize, and shut down facilities that fail to meet minimum standards.
The High Court hearing has therefore brought into public focus a long standing but often overlooked issue within the healthcare system. Diagnostic medicine cannot function in a regulatory vacuum.
For the medical community, this moment should prompt reflection and advocacy. Ensuring that diagnostic laboratories operate under qualified medical supervision is not merely a professional concern it is a patient safety imperative.
The credibility of clinical medicine ultimately depends on the reliability of the diagnostic evidence upon which it is built.
MBBS, PGDCMF (MNLU), MD (Forensic Medicine)
Hyderabad paediatrician Dr. Sivaranjani Santosh, who advocated for clearer ORS labelling, receives legal notice from companies linked to Kenvue and Johnson & Johnson.
The Rajasthan Government Health Scheme (RGHS) has been a lifeline for lakhs of state government employees, pensioners and their families but right now cashless medicine distribution at private OPD pharmacies has been suspended due to massive pending payments
A 45 year old patient named Biswajit Samanta from Nimta reportedly collapsed and died at RG Kar Medical College and Hospital after his family claims he was forced to walk to a distant toilet while in critical condition. No stretcher, wheelchair or assistance was provided despite repeated requests.
